Enlivex Therapeutics Ltd. (ENLV)

Enlivex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.75	0.81	49.95	11.2	5.67	3.95
Short-Term Investments	22.2	26.51	0.3	72.93	30.03	8.06
Cash & Short-Term Investments	25.94	27.32	50.24	84.13	35.71	12.01
Cash Growth	-10.24%	-45.63%	-40.28%	135.61%	197.36%	22.83%
Other Receivables	1.26	0.23	0.65	1.2	-	2
Receivables	1.26	0.23	0.65	1.2	-	2
Prepaid Expenses	1.14	1.11	1.44	1.11	1.24	0.91
Restricted Cash	-	-	-	-	1.17	1.5
Other Current Assets	0.23	5.11	-	-	-	-
Total Current Assets	28.57	33.76	52.33	86.44	38.12	16.42
Property, Plant & Equipment	2.03	10.2	14.9	8.22	2.14	1.06
Other Long-Term Assets	1.3	-7.14	0.41	0.49	0.1	0.08
Total Assets	31.9	36.83	67.64	95.15	40.36	17.56
Accounts Payable	0.3	0.83	1.95	0.88	0.46	0.24
Accrued Expenses	2.2	3.66	4.01	3.22	2.54	2.22
Current Portion of Leases	0.34	0.35	0.65	0.62	0.2	0.12
Other Current Liabilities	-	1.23	-	-	1.17	3.4
Total Current Liabilities	2.84	6.06	6.61	4.72	4.37	5.98
Long-Term Leases	0.5	0.69	4.19	5.39	0.5	0.3
Total Liabilities	3.34	6.75	10.8	10.11	4.87	6.28
Common Stock	2.39	2.14	2.12	2.11	1.65	1.15
Additional Paid-In Capital	144.41	138.94	136.65	133.8	70.36	37.1
Retained Earnings	-119.33	-112.09	-83.03	-51.97	-37.5	-25.67
Comprehensive Income & Other	1.1	1.1	1.1	1.1	0.98	-1.3
Total Common Equity	28.56	30.08	56.84	85.04	35.49	11.28
Shareholders' Equity	28.56	30.08	56.84	85.04	35.49	11.28
Total Liabilities & Equity	31.9	36.83	67.64	95.15	40.36	17.56
Total Debt	0.84	1.03	4.85	6.01	0.7	0.42
Net Cash (Debt)	25.11	26.29	45.4	78.12	35.01	11.59
Net Cash Growth	2.34%	-42.09%	-41.89%	123.18%	202.11%	18.52%
Net Cash Per Share	1.33	1.42	2.47	4.37	2.66	1.34
Filing Date Shares Outstanding	20.88	18.6	18.42	18.37	18.31	13.43
Total Common Shares Outstanding	20.88	18.6	18.42	18.33	14.59	10.33
Working Capital	25.73	27.7	45.72	81.72	33.75	10.44
Book Value Per Share	1.37	1.62	3.09	4.64	2.43	1.09
Tangible Book Value	28.56	30.08	56.84	85.04	35.49	11.28
Tangible Book Value Per Share	1.37	1.62	3.09	4.64	2.43	1.09
Machinery	2.75	3.36	3.38	2.34	1.53	0.91
Leasehold Improvements	1.43	8.67	8.61	1.52	0.71	0.15

Source: S&P Capital IQ. Standard template. Financial Sources.